(Q40435926)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15827327%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15827327%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

main subject

multiple drug resistance

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15827327%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Susan L. Cohn

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15827327%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Michelle Haber

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15827327%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

9

Wendy B London

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15827327%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Claudia Flemming Colussi

5

object named as

Claudia Flemming

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15827327%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

2

Janice Smith

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15827327%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Kara Tanabe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15827327%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Peter Tobin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15827327%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

George L Scheffer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15827327%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Peter Wielinga

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15827327%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Glenn M Marshall

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15827327%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

John D Allen

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15827327%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 April 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15827327%20AND%20SRC:MED&resulttype=core&format=json

Molecular Cancer Therapeutics

10 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15827327%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15827327%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15827327%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

547-553

1 reference